- Home
- Applications
- usa pennsylvania
- clinical medicine
- inflammatory response
Show results for
Refine by
Clinical Medicine Product Applications In Usa Pennsylvania
1 applications found
SFA Therapeutics novel immunomodualtor, SFA006 is planned for testing in COVID-19 Patients 4th Quarter 2020. The trial will test the compound’s ability to prevent the onset of Cytokine Storm Syndrome (CSS) and progression to Acute Respiratory Distress Syndrome (ARDS) in COVID-19 positive patients. Patients will be dosed and monitored for symptom progression hospitalization and ...
BySFA Therapeutics, Inc. based in Jenkintown, PENNSYLVANIA (USA)